Literature DB >> 16602117

Ceftriaxone induced hemolysis complicated by acute renal failure.

Gaurav Kapur1, Rudolph P Valentini, Tej K Mattoo, Indira Warrier, Abubakr A Imam.   

Abstract

Over the last decade, second and third generation cephalosporins have been the most common drugs causing hemolytic anemia (HA). Of these cases, 20% have been attributed to ceftriaxone. The clinical presentation of ceftriaxone-induced HA is usually abrupt with sudden onset of pallor, tachypnea, cardio-respiratory arrest and shock. Acute renal failure (ARF) has been reported in 41% of such cases with a high fatality rate. We report a pediatric patient with ARF complicating ceftriaxone-induced HA who survived. Ceftriaxone is a commonly used drug, and early recognition of HA and institution of supportive care, including dialysis is likely to improve the outcome. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 16602117     DOI: 10.1002/pbc.20839

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

Review 1.  Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.

Authors:  Christopher J A Duncan; David A Barr; R Andrew Seaton
Journal:  Int J Clin Pharm       Date:  2012-04-17

2.  Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up.

Authors:  Xiaowei Shen; Wang Liu; Xiaoliang Fang; Jianye Jia; Houwei Lin; Maosheng Xu; Hongquan Geng
Journal:  Int Urol Nephrol       Date:  2014-05-31       Impact factor: 2.370

3.  Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.

Authors:  Sandeep Kumar; Rohit Bansal; Priya Bansal; Rajinder Kumar Dhamija; Dnb Neurology
Journal:  Perm J       Date:  2019-12-18

4.  Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.

Authors:  Katarzyna Szajek; Marie-Elisabeth Kajdi; Valerie A Luyckx; Thomas Hans Fehr; Ariana Gaspert; Alexia Cusini; Karin Hohloch; Philipp Grosse
Journal:  BMC Nephrol       Date:  2021-01-08       Impact factor: 2.388

5.  Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report.

Authors:  Loic Raffray; Marie-Catherine Receveur; Mathilde Beguet; Pierre Lauroua; Thierry Pistone; Denis Malvy
Journal:  Malar J       Date:  2014-10-11       Impact factor: 2.979

Review 6.  Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.

Authors:  Hans Benno Leicht; Elke Weinig; Beate Mayer; Johannes Viebahn; Andreas Geier; Monika Rau
Journal:  BMC Pharmacol Toxicol       Date:  2018-10-25       Impact factor: 2.483

Review 7.  Nephrotoxicity as a cause of acute kidney injury in children.

Authors:  Ludwig Patzer
Journal:  Pediatr Nephrol       Date:  2008-01-29       Impact factor: 3.714

8.  An Uncommon Incidence of Drug-Induced Immune Hemolytic Anemia Secondary to Ceftriaxone.

Authors:  Aishwarya Sharma; Shannon Chamberlain; Devendranath Mannuru; Abhishek Matta
Journal:  Cureus       Date:  2021-12-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.